Abstract:Given that TLRs and sphingosine-1-phosphate (S1P) are key players in inflammation, we explored the potential interplay between TLRs and S1P in the adhesion/inflammatory pathways in primary human endothelial cells. As determined by Western blot and flow cytometry, cells treated with LPS (a TLR4 ligand) and S1P showed significantly enhanced expression of adhesion molecules such as ICAM-1 and E-selectin compared with the effect of either ligand alone. Cell-type differences on E-selectin upregulation were observed. In contrast, no cooperation effect on ICAM-1 or E-selectin was observed with a TLR2/TLR1 ligand. Consistent with an increase in adhesion molecule expression, endothelial cell treatment with LPS plus S1P significantly enhanced adhesion of PBMCs under shear stress conditions compared with the effect of either ligand alone and exhibited comparable levels of cell adhesion strength as those after TNF-a treatment. Moreover, LPS and S1P cooperated to increase the expression of proinflammatory molecules such as IL-6, cyclooxygenase-2, and prostacyclin, as determined by ELISA and Western blot. The analysis of signaling pathways revealed the synergistic phosphorylation of ERK upon LPS plus S1P treatment of HUVEC and human aortic endothelial cells and cell-type differences on p38 and NF-kB activation. Moreover, pharmacological and small interfering RNA experiments disclosed the involvement of S1P 1/3 and NF-kB in the cooperation effect and that cell origin determines the S1P receptors and signaling routes involved. Sphingosine kinase activity induction upon LPS plus S1P treatment suggests S1P– Sphingosine kinase axis involvement. In summary, LPS and S1P cooperate to increase proinflammatory molecules in endothelial cells and, in turn, to augment leukocyte adhesion, thus exacerbating S1P-mediated proadhesive/proinflammatory properties. S phingosine-1-phosphate (S1P) is a bioactive lipid mediator that mediates a wide spectrum of cell functions in both intracellular and extracellular compartments, which includes proliferation, migration, differentiation, angiogenesis, and lymphocyte trafficking (1–3). Many of the actions of S1P are mediated by the activation of receptors, initially known as endo-thelial differentiation genes and now designated as S1P 1–5 , which are high-affinity receptors coupled to G proteins (a io , a q , or a 12/13) that trigger the activation of multiple signals leading to specific cell responses (4). In addition, S1P can play an important role as a second messenger during inflammation (2). Accumulating evidence suggests an important role of S1P in the regulation of the immune system and the vascular system (2, 5). The S1P–S1P-receptor signaling axis has been implicated in a variety of pathophysiological conditions and diseases such …

Sphingosine-1-phosphate Receptor-2 Mediated NFκB Activation Contributes to Tumor Necrosis Factor-Α Induced VCAM-1 and ICAM-1 Expression in Endothelial Cells

Tumor Necrosis Factor-Alpha Induces Adhesion Molecule Expression Through the Sphingosine Kinase Pathway.

Sphingosine Kinase-1 Mediates Tnf-Alpha-Induced Mcp-1 Gene Expression in Endothelial Cells: Upregulation by Oscillatory Flow

Tanshinone II A Attenuates TNF-α-Induced Expression of VCAM-1 and ICAM-1 in Endothelial Progenitor Cells by Blocking Activation of NF-κB.

Sphingosine 1-phosphate receptor-3 enhances pro-inflammatory activity in human monocytes

Sphingosine 1-Phosphate Receptor-3 Enhances Pro-Inflammatory Activity in Human Monocytes (P1384)

Activation of Sphingosine Kinase by Tumor Necrosis Factor-α Inhibits Apoptosis in Human Endothelial Cells

Activation of nuclear factor-κB pathway is responsible for tumor necrosis factor-α-induced up-regulation of endothelin B2 receptor expression in vascular smooth muscle cells in vitro.

Sphingosine 1-phosphate and inflammation.

Sphingosine Kinase Interacts with TRAF2 and Dissects Tumor Necrosis Factor-α Signaling

Endothelial cell sphingosine 1-phosphate receptor 1 restrains VE-cadherin cleavage and attenuates experimental inflammatory arthritis

Sphingosine-1-Phosphate Receptor 2 Controls Podosome Components Induced by RANKL Affecting Osteoclastogenesis and Bone Resorption

Lipopolysaccharide and sphingosine-1-phosphate cooperate to induce inflammatory molecules and leukocyte adhesion in endothelial cells

Sphingomyelin Synthase 2 Deficiency Attenuates Nf Kappa B Activation

Chronic Increases in Sphingosine Kinase-1 Activity Induce A Pro-Inflammatory, Pro-Angiogenic Phenotype in Endothelial Cells

Leukocyte Adhesion in Endothelial Cells Induce Inflammatory Molecules and Sphingosine-1-Phosphate Cooperate To Lipopolysaccharide

Sphingosine 1-phosphate receptor 2 mediated early stages of pancreatic and systemic inflammatory responses via NF-kappa B activation in acute pancreatitis

S1P Increases VEGF Production in Osteoblasts and Facilitates Endothelial Progenitor Cell Angiogenesis by Inhibiting miR-16-5p Expression via the c-Src/FAK Signaling Pathway in Rheumatoid Arthritis

The crosstalk between neuropilin-1 and tumor necrosis factor-α in endothelial cells

Sphingosine 1-phosphate receptor 3 and RhoA signaling mediate inflammatory gene expression in astrocytes

Signaling controversy and future therapeutical perspectives of targeting sphingolipid network in cancer immune editing and resistance to tumor necrosis factor-α immunotherapy